Quantum Biopharma (QNTM) Non Operating Investment Income (2019 - 2026)
Quantum Biopharma's (QNTM) quarterly Non Operating Investment Income came in at $235807.0 in Q1 2026, up 261.17% quarter-over-quarter from -$146308.0 in Q3 2025.
Quantum Biopharma (QNTM) Non Operating Investment Income (2019 - 2026) Analysis & Trends
Quantum Biopharma has disclosed Non Operating Investment Income across 8 years of filings, most recently posting $235807.0 for Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 235,807.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 230,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 235,807.00 |
| Mar 31, 2026 | 235,807.00 |
| Sep 30, 2025 | -146,308.00 |
| Sep 30, 2025 | -146,308.00 |
| Jun 30, 2025 | -6,572.00 |
| Jun 30, 2025 | -6,572.00 |
| Mar 31, 2024 | -23,297.00 |
| Mar 31, 2024 | -23,297.00 |
| Sep 30, 2023 | 8,032.00 |
| Sep 30, 2023 | 8,032.00 |
| Jun 30, 2023 | -328,193.00 |
| Jun 30, 2023 | -328,193.00 |
| Mar 31, 2023 | 206,950.00 |
| Mar 31, 2023 | 206,950.00 |
| Sep 30, 2022 | -37,139.00 |
| Sep 30, 2022 | -37,139.00 |
| Jun 30, 2022 | 582,302.00 |
| Jun 30, 2022 | 582,302.00 |
| Mar 31, 2022 | -242,519.00 |
| Mar 31, 2022 | -242,519.00 |